Understanding Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
Exploring Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes reveals several interesting facts. Chair, Jacob Sands, MD, discusses
Key Takeaways about Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
- In this video series that was recorded in November 2025, leading oncologists present
- Chair & Presenter, Jacob Sands, MD, Ticiana A. Leal, MD, and Jared Weiss, MD, discuss
- Join Drs Sands, Leal, and Shields for a live CME-certified social media event featuring dynamic discussion on managing ...
- In this video series that was recorded in November 2025, leading oncologists present
- This content has been developed for healthcare professionals only.
Detailed Analysis of Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes
Stephen V. Liu, MD, Anna F. Farago, MD, PhD, and Leora Horn, MD, MSc, FRCPC, discuss Stephen V. Liu, MD, Jonathan W. Goldman, MD, Kristin Higgins, MD, Joanna-Grace M. Manzano, MD, MPH, FACP, and Gerard A. Dr. Cathy Pietanza from Memorial Sloan Kettering Cancer Center discusses standard chemotherapy
Chair, Taofeek K. Owonikoko, MD, PhD, Carl M. Gay, MD, PhD, and Jacob Sands, MD, discuss
Stay tuned for more updates related to Integrating New Options Into The Sclc Treatment Arsenal To Improve Patient Outcomes.
